Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1370586 | Bioorganic & Medicinal Chemistry Letters | 2011 | 6 Pages |
Twenty five 4-aminomethylidene derivatives obtained from 3-phenyl-2-pyrazolin-5-one and 1,3-diphenyl-2-pyrazolin-5-one were synthesized and tested for their antiproliferative activity against human breast cancer MDA-MB-361 and MDA-MB-453 cell lines. The compounds derived from 1,3-diphenyl-2-pyrazolin-5-one exhibited the most remarkable activity in the treatment of both cell lines. In vitro antiproliferative activities were accompanied by an important apoptotic fraction of both cell lines; also, compounds inhibited key endothelial cell functions implicated in invasion and angiogenesis. QSAR methods were performed in order to analyze the influence of structural features of the compounds investigated on the antiproliferative potential on MDA-MB-361 and MDA-MB-453 cancer cells. One-parameter heuristic analysis was performed and different whole molecule and fragmental descriptors were considered for rationalization of mechanism of interaction of these compounds with active place of hypothetical target included in tumorigenesis.
Graphical abstractSeveral new 4-aminomethylidene derivatives of two pyrazol-5-ones were found to be very active against human breast cancer MDA-MB-361 and MDA-MB-453 cell lines.Figure optionsDownload full-size imageDownload as PowerPoint slide